SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,386,440 | -7.3% | 5,092,000 | +1.1% | 2.15% | -1.8% |
| Q2 2023 | $151,382,160 | -3.9% | 5,036,000 | +15.8% | 2.19% | -3.5% |
| Q1 2023 | $157,600,500 | +1.4% | 4,350,000 | -0.1% | 2.27% | -16.3% |
| Q4 2022 | $155,378,520 | -0.1% | 4,356,000 | -5.2% | 2.71% | +0.5% |
| Q3 2022 | $155,473,000 | +14.1% | 4,593,004 | -2.5% | 2.70% | +13.5% |
| Q2 2022 | $136,271,000 | +36.0% | 4,712,000 | +52.0% | 2.38% | +22.7% |
| Q1 2022 | $100,192,000 | -16.9% | 3,100,000 | -25.0% | 1.94% | -1.9% |
| Q4 2021 | $120,606,000 | +16.0% | 4,136,000 | +6.1% | 1.97% | +12.0% |
| Q3 2021 | $104,013,000 | +1.6% | 3,900,000 | +17.3% | 1.76% | -3.8% |
| Q2 2021 | $102,346,000 | +14.6% | 3,324,000 | -2.6% | 1.83% | -10.7% |
| Q1 2021 | $89,326,000 | +13.8% | 3,412,000 | +9.4% | 2.05% | -23.2% |
| Q4 2020 | $78,499,000 | +17.7% | 3,120,000 | -2.5% | 2.67% | +10.4% |
| Q3 2020 | $66,688,000 | +27.2% | 3,200,000 | +44.9% | 2.42% | +5.2% |
| Q2 2020 | $52,440,000 | -2.8% | 2,208,000 | -26.4% | 2.30% | -31.1% |
| Q1 2020 | $53,970,000 | +32.9% | 3,000,000 | +75.2% | 3.34% | +42.4% |
| Q4 2019 | $40,609,000 | – | 1,712,000 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |